Sutetinib for Patients with Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase IIb Trial
用户EO9nReo4Hj6s
1个月前
96
10
已完结
1. 系统已在2026-09-11 14:39:17对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.jtho.2026.104165
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1556086426006180
其他信息:
出版社: Elsevier BV
作者: Fengying Wu; Wei Zhang; Yanqiu Zhao; Yan Yu; Jian Fang; Sen Han; Mingfang Zhao; Wenxiu Yao; Yang Wei; Jianhua Shi; Jianhua Chen; Xingya Li; Wei Hong; Rui Meng; Yongqian Shu; Chenzhi Zhou; Zhengguang Zhou; Ying Hu; Jianchun Duan; Huiqing Yu; Mengzhao Wang; Petros George Nikolinakos; Xiuning Le; Baohui Han; Caicun Zhou
